Showing results (151-160 of 757) with videos related to
Sort By:
Pageof 76
Journal of Cellular Biochemistry|June 5, 2007
Synergistic induction of osteopontin by aldosterone and inflammatory cytokines in mesangial cellsStefan Gauer, Ingeborg A Hauser, Nicholas Obermüller, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|June 17, 2009
Combination therapy with various combinations of aliskiren, valsartan, and hydrochlorothiazide in hypertensive patients not adequately responsive to hydrochlorothiazide aloneHelmut Geiger, Elizabeth Barranco, Manuel Gorostidi, et al.International Journal of Molecular Sciences|August 31, 2018
Tracking of Adipose-Derived Mesenchymal Stromal/Stem Cells in a Model of Cisplatin-Induced Acute Kidney Injury: Comparison of Bioluminescence Imaging versus qRT-PCRRalf Schubert, Julia Sann, Jochen T Frueh, et al.Circulation Research|August 23, 2003
Extracellular superoxide dismutase is a major determinant of nitric oxide bioavailability: in vivo and ex vivo evidence from ecSOD-deficient miceOliver Jung, Stefan L Marklund, Helmut Geiger, et al.The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|March 23, 2004
Immunohistochemical and mRNA localization of the angiotensin II receptor subtype 2 (AT2) in follicular granulosa cells of the rat ovaryNicholas Obermüller, Monika Gentili, Stefan Gauer, et al.Blood Purification|July 3, 2017
Anatomy Revisited: Hemodialysis Catheter Malposition in the Left Ascending Lumbar VeinStefan Büttner, Sammy Patyna, Sarah Rudolf, et al.International Journal of Molecular Sciences|February 11, 2023
Gliflozins Have an Anti-Inflammatory Effect on Renal Proximal Tubular Epithelial Cells in a Diabetic and Inflammatory Microenvironment In VitroBenjamin Koch, Dominik C Fuhrmann, Ralf Schubert, et al.PPAR Research|March 27, 2012
Rosiglitazone affects nitric oxide synthases and improves renal outcome in a rat model of severe ischemia/reperfusion injuryBoris Betz, Reinhard Schneider, Tobias Kress, et al.Therapeutics and Clinical Risk Management|February 2, 2017
Advances in the management of cardiovascular risk for patients with type 2 diabetes: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 DiabetesGuntram Schernthaner, Sarah Jarvis, Chaim Lotan, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 14, 2010
The issue of studying the effect of interventions in renal replacement therapy -- to what extent may we be deceived by selection and competing risk?Kitty J Jager, Vianda S Stel, Carmine Zoccali, et al.Pageof 76